NH
Nicholas Holowko UBS Latest Price Targets & Analyst Ratings
Main Sector
Financials
Ratings Past Year
17
Avg Return
Past Year
Past Year
1.6%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
30%
Neutral
70%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Financials
Healthcare
Financials
Banks - Regional
Credit Services
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Downgraded
| $75 |
7%
upside
| 1 | +8% |
–
| 5 Feb ‘26 1 month ago |
|
|
|
Buy
Initiated
| $56 |
46%
upside
| 1 | -18% |
0
%
| 8 Jan ‘26 2 months ago |
|
|
|
Buy
Initiated
| $92 |
25%
upside
| 1 | -8.5% |
0
%
| 8 Jan ‘26 2 months ago |
|
|
|
Buy
Initiated
| $15 |
22%
upside
| 1 | +2.3% |
0
%
| 15 Dec ‘25 2 months ago |
|
|
|
Neutral
Initiated
| $25 |
10%
upside
| 1 | – |
–
| 15 Dec ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $34 |
2%
downside
| 1 | – |
–
| 5 Nov ‘25 4 months ago |
|
|
|
Buy
Maintained
| $2,250 |
15%
upside
| 1 | +7.5% |
0
%
| 5 Nov ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $11.50 |
10%
downside
| 1 | – |
–
| 5 Nov ‘25 4 months ago |
|
|
|
Buy
Maintained
| $105 |
41%
upside
| 1 | -3.7% |
0
%
| 5 Nov ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $49 | – | 2 | -5.7% |
–
| 5 Nov ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $95 |
7%
upside
| 1 | – |
–
| 5 Nov ‘25 4 months ago |
|
|
|
Buy
Maintained
| $120 |
26%
upside
| 1 | +8.1% |
0
%
| 5 Nov ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $57 |
1%
upside
| 1 | – |
–
| 5 Nov ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $115 |
5%
upside
| 1 | – |
–
| 28 Oct ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $50 |
10%
upside
| 1 | – |
–
| 28 Oct ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $127 |
4%
downside
| 1 | – |
–
| 24 Oct ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $68 |
30%
downside
| 2 | – |
–
| 30 Jul ‘25 7 months ago |
|
|
|
Neutral
Upgraded
| $59 | – | 1 | +17% |
–
| 10 Apr ‘25 11 months ago |
|